Itonis, Inc.
ITNS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$609.36K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $609,364.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.26 |
| Outstanding Shares | 1,523,409,834 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -51.16 |
|---|---|
| PEG | -740.62 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Itonis, Inc.
3 employees
CEO: Mark H. Cheung
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to ...